Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Blood compatibility – it’s all in the genes!


In most developed countries safe blood transfusion is taken for granted. But blood grouping is a complex business, and not all blood groups are compatible. In order to check for compatibility, two cross-matching tests are carried out prior to transfusion - but these tests are based on technology that has not changed since the early days of blood transfusions.

Now a consortium called Bloodgen, led by the University of the West of England (UWE), Bristol, is nearing the end of a three-year project that aims to use genotyping to improve patient safety and blood transfusion compatibility. The project will include the launch of a CE-marked commercial product Bloodchip which will be sold to Blood Services worldwide. A Research TV film on the project, entitled ‘Compatibility – it’s all in the genes’ – can be seen at

Currently, the two blood groups are tested for routinely ABO and Rh (Rhesus). However there are 29 different blood group systems Not all blood groups are compatible and mixing incompatible groups can put some people at risk. Bloodchip tests for 9 of these systems, which includes all clinically relevant blood groups.

The blood group to which people belong depends on the combination of antigens built into their DNA and antibodies to antigens they have previously been exposed to. The genotyping test extracts DNA from blood and uses a gene chip, a small microscope slide capable of performing up to 300 reactions, to compare donated blood with that of a potential recipient.

Professor Neil Avent, director of UWE’s Centre for Research in Biomedicine and leader of the project said:

“Blood grouping at the moment uses antibodies that interact with proteins on the surface of cells. Genotyping is looking at the genes: our research looks at the blood group specific genes which vary from one individual to another. This is certainly a safer means of testing blood because of its comprehensiveness. The chip will embrace all blood groups that are clinically significant and we’ll be able to have those tested on a routine basis.

“The ultimate goal is that a new technology will come in and replace techniques that have been around for 100 years or so. Genotyping is incredibly accurate and could be used for a wide range of routine testing of patients in the near future.”

Lesley Drake | alfa
Further information:

More articles from Health and Medicine:

nachricht NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases

nachricht Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

Im Focus: Surveying the Arctic: Tracking down carbon particles

Researchers embark on aerial campaign over Northeast Greenland

On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...

Im Focus: Unique Insights into the Antarctic Ice Shelf System

Data collected on ocean-ice interactions in the little-researched regions of the far south

The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...

Im Focus: ILA 2018: Laser alternative to hexavalent chromium coating

At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.

When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...

Im Focus: Radar for navigation support from autonomous flying drones

At the ILA Berlin, hall 4, booth 202, Fraunhofer FHR will present two radar sensors for navigation support of drones. The sensors are valuable components in the implementation of autonomous flying drones: they function as obstacle detectors to prevent collisions. Radar sensors also operate reliably in restricted visibility, e.g. in foggy or dusty conditions. Due to their ability to measure distances with high precision, the radar sensors can also be used as altimeters when other sources of information such as barometers or GPS are not available or cannot operate optimally.

Drones play an increasingly important role in the area of logistics and services. Well-known logistic companies place great hope in these compact, aerial...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

International Virtual Reality Conference “IEEE VR 2018” comes to Reutlingen, Germany

08.03.2018 | Event News

Latest News

Wandering greenhouse gas

16.03.2018 | Earth Sciences

'Frequency combs' ID chemicals within the mid-infrared spectral region

16.03.2018 | Physics and Astronomy

Biologists unravel another mystery of what makes DNA go 'loopy'

16.03.2018 | Life Sciences

Science & Research
Overview of more VideoLinks >>>